Search the Newsreel

Shimmick Corp (SHIM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

The article provides a revenue breakdown for Shimmick Corp (SHIM) by business segment, including fixed-price, cost reimbursable, and equipment and labor revenue. It shows the proportion of revenue generated by each segment, with fixed-price contracts accounting for the vast majority. The data was updated …

Immunic Inc (IMUX) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for Immunic Inc (IMUX), including sections on operating, investing, and financing cash flows. It also offers a FAQ section defining these terms and providing specific cash flow figures for Immunic Inc, such as …

Immuron Ltd (IMRN) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Immuron Ltd (IMRN), indicating a "Buy" rating based on one analyst's assessment. The target price for IMRN is set at USD 5.00, representing a significant upside. The report includes current market data and a peer comparison, but …

Immuron Ltd (IMRN) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Immuron Ltd (IMRN), focusing on its volatility, financial risk, and investment risk based on various metrics. It details the company's market performance, including daily returns, drawdowns, Sharpe Ratios, and different measures of volatility and liquidity. The data …

BitMine Nearing Inflection Point as Ethereum Buying Nears Key Target

BitMine Immersion (BMNR) is approaching a significant turning point as it nears its target of accumulating 6 million Ethereum (ETH) coins. This move is expected to end share dilution and allow the company to transition into a cash generator through Ethereum staking, yielding an …

MindWalk Holdings Corp. 2026 Q4 - Results - Earnings Call Presentation (NASDAQ:HYFT) 2026-07-26

This article announces that MindWalk Holdings Corp. has published its slide deck in conjunction with their 2026 Q4 earnings call. The content is an earnings call presentation for the company, traded under the NASDAQ symbol HYFT, dated July 26, 2026.

Immuron Ltd (IMRN) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Immuron Ltd (IMRN), focusing on various indicators and moving averages. It presents a summary of "Sell," "Neutral," and "Buy" signals from nine common technical indicators and six moving averages. The analysis concludes with a "Neutral" signal based …

Shimmick Corp (SHIM) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Shimmick Corp (SHIM) dividends and stock splits, noting that no dividend data is available and zero dividends have been distributed in the past five years. It presents basic stock information, including the current price, market cap, and links …

Immix Biopharma, Inc. Revenue Breakdown – NASDAQ:IMMX

This article provides an overview of Immix Biopharma, Inc. (NASDAQ: IMMX), focusing on its revenue breakdown and financial data available on TradingView. It highlights the company's financial segment performance and regional contributions, emphasizing that this data is sourced from ICE Data Services and FactSet. …

Estrella Immunopharma Inc (ESLA) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Estrella Immunopharma Inc (ESLA), listing major individual and institutional holders. It specifies the proportion of shares held by different types of shareholders, including corporations, individual investors, and various investment firms. The report also includes historical institutional shareholding …

ETFs Investing in Altimmune, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of Altimmune, Inc. (ALT). It provides a detailed table including each ETF's market value, weight of ALT stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change, relative volume, and …

Immersion Corp (IMMR) Cash Flow Statement

This article provides the quarterly and annual cash flow statements for Immersion Corp (IMMR), detailing operating, investing, and financing cash flows, along with free cash flow. It includes definitions and FAQs for key cash flow metrics like operating cash flow, investing cash flow, financing …

Altimmune Inc (ALT) Income Statement

This article provides a detailed quarterly and annual income statement for Altimmune Inc (ALT) from 2012 to 2026, offering insights into its financial performance, including total revenue, operating expenses, and net income. It also includes an FAQ section explaining how to interpret the income …

Simmons First National Corporation Class A Revenue Breakdown – LSX:922248

The article details the revenue breakdown for Simmons First National Corporation Class A (LSX:922248). In the last year, the company generated 770.79 million EUR, with its top segment, Community and Commercial Banking, contributing 52.45 million EUR. The United States was the primary regional contributor, …

Immunovant Inc (IMVT) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Immunovant Inc (IMVT), listing major shareholders and their respective proportions, along with a breakdown by shareholder types. It also provides institutional shareholding data over several quarters and an overview of related ETF holdings. Key holders include Roivant …

Shimmick Corp (SHIM) Income Statement

This article provides the quarterly and annual income statements for Shimmick Corp (SHIM), detailing revenue, operating profit, net income, and earnings per share. It allows users to analyze the company's financial performance and operational efficiency, including year-over-year comparisons for various financial metrics. The document …

Immuncore Holdings PLC IMCR Income Statement

This article presents the quarterly and annual income statements for Immunocore Holdings PLC (IMCR), offering a detailed breakdown of its financial performance over several years. It includes key metrics such as total revenue, cost of revenue, operating expenses, net income, and earnings per share. …

SHIM|Shimmick Corp|Price:3.650|Chg%:-0.020

This article provides a detailed financial overview of Shimmick Corp (SHIM), including its stock performance, earnings date, and various financial indicators. It presents quarterly and annual data for revenue, EPS, net profit, net margin, gross margin, and debt to assets ratio, along with balance …

Immatics NV (IMTX) Cash Flow

This article provides a detailed cash flow statement for Immatics NV (IMTX), broken down by operating, investing, and financing activities on both quarterly and annual bases. It includes financial figures, year-over-year changes, and a section of FAQs defining cash flow terms and summarizing Immatics …

Immatics N.V. Revenue Breakdown – NASDAQ:IMTX

Immatics N.V. (NASDAQ:IMTX) reported a revenue of $56.73 million USD last year. The majority of this revenue, $54.47 million USD, was generated by its PRAME-directed Immunotherapies segment, primarily from the United States. This represents a significant decrease compared to the previous year's total revenue …

Zimmer Biomet Holdings Inc (ZBH) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a historical overview of dividend payouts for Zimmer Biomet Holdings Inc (ZBH), detailing past and upcoming interim and final cash dividends. It lists dividend amounts, record dates, payment dates, and ex-dividend dates for quarterly payouts, consistently showing a gross dividend of …

Immuron Ltd (IMRN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Immuron Ltd (IMRN) for Fiscal Year 2023, showcasing its business segments and regional contributions. Travelan accounts for the vast majority of revenue at 96.68%, with Protectyn making up the remaining 3.32%. Geographically, Australia generates 64.31% of revenue, …

Immuron Ltd (IMRN) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details on the dividend and stock split history for Immuron Ltd (IMRN). It states that the company has distributed a total of $0.00 in dividends over the past five years and shows "No Data" for specific dividend dates. The article includes …

IMTX|Immatics NV|Price:9.080|Chg%:-0.210

Immatics NV is a Netherlands-based clinical-stage biopharmaceutical company focused on developing T-Cell receptor immunotherapies for solid tumors. The company employs two therapeutic modalities: Adoptive Cell Therapies (ACT) and antibody-like TCR Bispecifics (TCER), with several programs in clinical trials and preclinical development. Its executive team …

IMMP|Immutep Ltd|Price:0.385|Chg%:-0.008

This article provides an overview of Immutep Ltd (IMMP) with its current stock price and change percentage. It details how TradingKey generates its stock scores, covering dimensions like financial health, company valuation, earnings forecasts, price momentum, institutional confidence, and risk management. However, it notes …

Immunovant Inc (IMVT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Immunovant Inc (IMVT), covering key indicators like MACD, RSI, and Moving Averages. It summarizes the current signals for IMVT, indicating an overall neutral signal based on today's moving averages and other technical indicators. The analysis notes 5 …

TradingKey

This article provides a detailed quarterly and annual income statement for Immatics NV (IMTX), offering insights into the company's financial performance and operational efficiency. It presents data spanning several years for various financial metrics such as total revenue, operating expenses, net income, and earnings …

Immersion (IMMR) Stock Faces 0.3% Net Margin Reality Challenging Bullish Narratives

ACIU|AC Immune SA|Price:2.230|Chg%:-0.010

AC Immune SA (ACIU) is a clinical-stage biopharmaceutical company focusing on neurodegenerative diseases. The stock is currently priced at $2.230, down 0.45%, and holds a "Strong Buy" rating from analysts with a target price of $8.60. Despite recent weak stock market performance, its fundamentals …

Zimmer Biomet Holdings Inc (ZBH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Zimmer Biomet Holdings Inc (ZBH), detailing its performance by business segments and regional contributions. As of a recent update, the company's revenue is primarily driven by its Knees, S E T, and Hips product categories, with the …

Immix Biopharma Inc (IMMX) Income Statement

Altimmune, Inc. Revenue Breakdown – NASDAQ:ALT

Form 4 Immunovant Inc For: 24 July By Investing.com

This article reports on the filing of Form 4 for Immunovant Inc. on July 24, as published by Investing.com. Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) by company insiders to report changes in beneficial …

Immunome Inc (IMNM) Institutional Confidence

Immunome Inc (IMNM) has an institutional shareholding score of 10.00, ranking 1st in the Biotechnology & Medical Research industry, with institutional ownership at 102.66%, up 21.95% quarter-over-quarter. James Simons is the largest institutional shareholder, holding 0.06% of shares outstanding. Key institutional investors include Fidelity …

Bitmine Immersion Technologies (BMNP) director gains 4,749 shares on RSU vesting

Bitmine Immersion Technologies director Robert J. Sechan II reported the vesting of 4,749 Restricted Stock Units (RSUs) on July 23, 2026. These RSUs settled into common shares at $0 per share, increasing his direct holdings to 48,137 common shares and leaving him with 9,498 …

MindWalk Holdings Corp. (HYFT) Interactive Stock Chart

This page provides an interactive stock chart for MindWalk Holdings Corp. (HYFT) on Yahoo Finance. It displays a summary of their stock performance, recent news related to the company including earnings reports and AI drug discovery developments, and data on related tickers in the …